Abstract
Hepatitis B virus (HBV) genotypes affect the pathogenesis of disease progression during the course of HBV infection. In Japan, HBV genotype H is one of the rare HBV genotypes. We recovered HBV genotype H from a blood sample from a Japanese HIV-infected patient with acute exacerbation of chronic HBV infection. Due to the development of drugs for treating HBV and HIV, HBV genotype H and HIV coinfection has been well controlled by nucleos(t)ide analogs and highly active antiretroviral therapy, respectively, from 2002 to 2019. Further study is needed with regard to HBV genotype H and its pathogenesis.
| Original language | English |
|---|---|
| Pages (from-to) | 633-639 |
| Number of pages | 7 |
| Journal | Future Virology |
| Volume | 14 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- HBV
- HIV
- Japan
- genotype H
- lamivudine
- long-term observation
- nucleos(t)ide analogs
Fingerprint
Dive into the research topics of 'Long-term follow-up of a Japanese patient with hepatitis B virus genotype H and human immunodeficiency virus coinfection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver